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ABSTRACT

An endoluminal graft system comprising an endoluminal
graft including a framework and a flexible fabric surrounding the framework, a deflection means configured for placement through an opening to a branching vessel, and a
delivery catheter configured to position the endoluminal
graft within a primary vessel. A method of implanting the
endoluminal graft includes positioning the endoluminal
graft within a primary vessel with a leading edge of the
endoluminal graft adjacent to an opening to a branching
vessel. A deflecting means is positioned through the opening
to the branching vessel adjacent to the leading edge of the
endoluminal graft. The endoluminal graft is then advanced
along the length of the primary vessel with the deflection
means engaging the leading edge of the endoluminal graft to
form a scallop along the leading edge of the endoluminal
graft.
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ENDOLUMINAL GRAFT SYSTEM AND
METHOD OF IMPLANTING THE SAME

intended seal zone of the endoluminal graft. However,
scallops require custom manufacture of a graft based on the
patient's anatomy, an issue which is complicated when more
than one scallop is required. Furthermore, extreme care must
be taken to ensure that the scallops are properly aligned with
the branch vessel during deployment of the endoluminal
graft in order to avoid obstructing blood flow into the branch
vessel.

CROSS-REFERENCE TO RELATED
APPLICATIONS
The present application is a continuation of U.S. patent
application Ser. No. 15/352,516 filed on Nov. 15, 2016,
which claims priority to U.S. Provisional Patent Application
Ser. No. 62/255,496 filed on Nov. 15, 2015, the entire
disclosures of which are incorporated herein by reference.
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TECHNICAL FIELD
The present invention relates to an endoluminal graft
system and method of implanting the same. In particular, the
present invention relates to a system and method in which
scallops are formed in-situ during the delivery and deployment of an endoluminal graft.
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BACKGROUND OF THE INVENTION
An aneurysm is a degenerative dilation of a portion of a
blood vessel that can ultimately lead to rupture of the vessel
and life-threatening blood loss. As shown in FIG. 1, one of
the most common sites of an aneurysm 105 is the infra-renal
aorta 101 between the renal arteries 102 and the iliac vessels
106.
Referring now to FIG. 2, endovascular aneurysm repair
(EVAR) is a minimally invasive procedure, which involves
placing a tubular prosthesis 110 within the diseased blood
vessel to act as an impervious liner which prevents the
systemic pressure from pushing on the aneurysm 105. In
particular, such prostheses 110 are generally made of a
blood-impervious fabric such as polytetrafluorethylene
(PTFE) or polyester (PET) that is supported along at least a
portion of its length by a framework or skeleton. The
framework or skeleton is commonly a metal (e.g., nitinol,
stainless steel, chromium cobalt, etc.) or an injectable polymer. To be effective, the prosthesis must achieve circumferential wall apposition (or seal) with the inner wall of a
healthy portion of the blood vessel, or vessels, proximal and
distal to the aneurysm 105. For standard EVAR, the proximal seal is made in a healthy portion 104 of the aorta 101
distal to the openings 103 of the renal arteries 102. As shown
in FIG. 2, since most infra-renal aneurysms extend to the
terminal bifurcation of the aorta 101, most endovascular
prostheses 110 for this location incorporate a bifurcated
design, allowing for the distal seal to be achieved in each of
the iliac vessels 106.
Referring still to FIG. 2, many endovascular prostheses
110 consist of a flat-topped fabric supported by a framework
configured as a series of peaks and indentations. To achieve
an effective seal, the proximal end of the graft 110 must have
circumferential wall contact with the healthy portion 104 of
the aorta 101. It is generally recommended that the longitudinal length of the healthy portion 104 of the aorta 101 be
at least 15 mm to achieve a seal of sufficient length to ensure
a long-term successful seal. However, in some cases, the
aneurysm 105 arises too close to the renal arteries 102 to
achieve this length of seal.
One known solution is to use an endoluminal graft with a
scallop formed in the fabric of the endoluminal graft. A
scallop, as used herein, is a deflection or discontinuity of the
normally straight edge of the fabric of the endoluminal graft.
Such scallops, can allow preservation of flow to important
branch vessels such as the renal arteries that arise in the
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SUMMARY OF THE INVENTION
The present invention is an endoluminal graft system and
method of implanting the same in which scallops are formed
in-situ during the delivery and deployment of the endoluminal graft, thereby ensuring proper alignment of the scallop
with the branching vasculature and obviating the need for
custom manufacturing of grafts with preformed scallops.
An exemplary endoluminal graft, or graft, used as part of
the system and method of the present invention generally
comprises a framework and a flexible fabric surrounding the
framework. The framework of the graft includes a plurality
of curvilinear elements with an uppermost element defining
a plurality of alternating peaks and indentations. Furthermore, the flexible fabric defines a leading edge which
initially extends between the peaks substantially flat across
the indentations defined by the framework of the graft. In
this way, the leading edge of the flexible fabric is also the
leading edge of the graft. Furthermore, because a portion of
the flexible fabric extends above the framework (i.e., across
the indentations), the leading edge of the flexible fabric is
deformable, as further discussed below.
In a first step of an exemplary implementation of the
method of the present invention, the graft is positioned
within a primary vessel, such as the aorta, extending through
an aneurysm and into a healthy portion of the aorta with the
leading edge of the flexible fabric adjacent to an opening to
a branching vessel, or vessels, such as the renal arteries. As
previously mentioned, when the graft is first positioned
within the aorta, the leading edge of the flexible fabric
extends substantially flat between the peaks of the framework.
After positioning the graft with the leading edge adjacent
to the openings of the renal arteries, a deflection means, for
example a balloon, is positioned through the opening of each
of the renal arteries and subsequently inflated. In other
words, a distal portion of the balloon is positioned and
temporarily secured within the renal artery while a proximal
portion of the balloon remains within the aorta itself. The
balloon therefore acts as a physical extension of the renal
arteries into the aorta.
After the balloons are positioned and inflated, the graft is
advanced along the length of the aorta, such that the balloons
engage the leading edge of the flexible fabric and cause the
flexible fabric to deflect and form scallops along the leading
edge of the flexible fabric and within the indentations of the
framework. Advantageously, since the balloons are inflated
so as to be secured within the renal arteries, the scallops are
aligned with each of the renal arteries. That is to say, the
system and method of the present invention are configured
such that the balloons, or other such deflection means, align
the indentations of the framework with the renal arteries so
that the resulting scallops are also properly aligned with the
renal arteries. In particular, as the graft is advanced along the
length of the aorta and the balloons begin to deflect the
flexible fabric, the balloons engage the indentations of the
underlying framework. As the balloons slide down the
framework and into the indentations, the balloons cause the

US 10,667,899 Bl
3

4

graft to rotate so as to aligned the indentation with the
balloon extending from the renal artery. The resulting scallops formed within the indentation are therefore aligned with
the balloons and no scallops are formed along the portion of
the leading edge where the balloons are not present, as
further discussed below.
The balloons are, in some exemplary implementations of
the method of the present invention, introduced by a distal
approach, such that the balloons pass through the graft itself
before being positioned through the openings of the renal
arteries, but in other exemplary implementations of the
present invention, the balloons are introduced by a proximal
approach.
After the scallops are formed along the leading edge of the
graft, the balloons are deflated and removed from the
openings to the renal arteries. The graft is now positioned
within the aorta with a proximal seal made in the healthy
portion of the aorta proximal to the aneurysm. Advantageously, in the exemplary system and method of the present
invention, it is only the portions of the leading edge of graft
which are aligned with the openings to the renal arteries (i.e.,
where the balloons were previously positioned) that is
deflected to create the scallops. The remaining portion of the
leading edge is not deflected and extends above the openings
to the renal arteries. As such, even when the aneurysm is
relatively close to the renal arteries, the area of the flexible
fabric in contact with the healthy portion of the aorta
provides a sufficient seal while still preserving blood flow to
the renal arteries.
Further features and advantages of the present invention
will become evident to those of ordinary skill in the art after
a study of the description, figures, and non-limiting
examples in this document.

FIG. 10 depicts the proximal seal zone of FIG. 9 after the
graft is advanced and each balloon has formed a scallop in
the leading edge of the flexible fabric;
FIG.11 depicts the proximal seal zone ofFIG.10 after the
tethers are detached;
FIG. 12 depicts a proximal seal zone of another exemplary endoluminal graft of the present invention with two
balloons, introduced by a distal approach, positioned and
inflated within each of the renal arteries;
FIG. 13 depicts a proximal seal zone of another exemplary endoluminal graft of the present invention; and
FIG. 14 depicts a distal seal zone of another exemplary
endoluminal graft of the present invention with a scallop
aligned with the opening to a branching artery.
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DESCRIPTION OF THE INVENTION
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DESCRIPTION OF THE DRAWINGS
FIG. 1 depicts an aneurysm in the infra-renal aorta of a
patient's vasculature;
FIG. 2 depicts an endoluminal graft known in the prior art
deployed within the vasculature of FIG. 1;
FIG. 3 depicts a proximal seal zone of an exemplary
endoluminal graft of the present invention positioned via a
delivery catheter;
FIG. 4Adepicts the proximal seal zone of FIG. 3 with two
balloons, introduced by a distal approach, positioned and
inflated within each of the renal arteries;
FIG. 4B depicts the proximal seal zone of FIG. 3 with two
balloons, introduced by a proximal approach, positioned and
inflated within each of the renal arteries;
FIG. SA depicts the proximal seal zone of FIG. 4A after
the graft is advanced and each balloon has formed a scallop
in the leading edge of the flexible fabric;
FIG. 5B depicts the proximal seal zone of FIG. 4B after
the graft is advanced and each balloon has formed a scallop
in the leading edge of the flexible fabric;
FIG. 6 is an oblique view of the graft of FIG. SA after the
balloons are removed showing the scallops aligned with the
openings to the renal arteries;
FIG. 7 depicts the proximal seal zone of FIG. SA with
stents deployed in each of the renal arteries;
FIG. 8 depicts a proximal seal zone of another exemplary
endoluminal graft of the present invention positioned via a
delivery catheter having a plurality of tethers;
FIG. 9 depicts the proximal seal zone of FIG. 8 with two
balloons, introduced by a distal approach, positioned and
inflated within each of the renal arteries;
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The present invention relates to the design of endoluminal
graft systems, which are medical devices designed to treat
vascular pathology such as aneurysms or dissections and
methods of implanting the same. More specifically, the
invention is an endoluminal graft system, and method of
implanting the same, in which scallops are formed in-situ
during the delivery and deployment of the endoluminal
graft, thereby ensuring proper alignment of the scallop with
the branching vasculature and obviating the need for custom
manufacturing of grafts with preformed scallops.
Referring now to FIGS. 3-6, an exemplary endoluminal
graft, or graft, 210 used as part of the system and method of
the present invention generally comprises a framework 220
and a flexible fabric 230 surrounding the framework 220.
The framework 220 of the graft 210 includes a plurality of
curvilinear elements with an uppermost element defining a
plurality of alternating peaks 224 and indentations 226.
Furthermore, the flexible fabric 230 defines a leading edge
232 which, as shown in FIG. 3, initially extends between the
peaks 224 substantially flat across the indentations 226
defined by the framework 220 of the graft 210. In this way,
the leading edge 232 of the flexible fabric 230 is also the
leading edge 232 of the graft 210. Furthermore, because a
portion of the flexible fabric 230 extends above the framework 220 (i.e., across the indentations 226), the leading edge
232 of the flexible fabric 230 is deformable, as further
discussed below.
Referring now specifically to FIG. 3, in a first step of an
exemplary implementation of the method of the present
invention, the graft 210 is positioned within a primary vessel
of a patient, such as the patient's aorta 101, extending
through an aneurysm 105 and into a healthy portion 104 of
the aorta 101 with the leading edge 232 of the flexible fabric
230 adjacent to an opening 103 to a branching vessel, or
vessels, such as the renal arteries 102. As previously mentioned, when the graft 210 is first positioned within the aorta
101, the leading edge 232 of the flexible fabric 230 extends
substantially flat between the peaks 224 of the framework
220.
Although not shown in the Figures, it should be understood by one skilled in the art that the graft 210 may be
positioned by way of the patient's femoral artery or by other
common techniques. Typically, the graft 210 is placed in
communication with the interior of the patient's vessel while
the graft 210 is in an undeployed configuration which is
substantially narrower than the fully deployed configuration.
In some embodiments, a delivery sheath or other similar
device known in the art, may further assist in placement of
the graft 210, however, in other embodiments a delivery
sheath may not be needed. In either event, as shown in FIG.
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3, the delivery sheath and/or graft 210 are guided by a
delivery catheter 200 into position within the aorta 101, and,
subsequently, the graft 210 is deployed. As shown in the
Figures, the delivery catheter 200 includes a nose cone 204
which is advanced along a guidewire 202 and which precedes a guidewire lumen 206 that is disposed around the
guidewire 202.
Referring now specifically to FIG. 4A, after positioning
the graft 210 with the leading edge 232 adjacent to the
openings 103 of the renal arteries 102, a deflection means
300, which in the embodiment shown in FIG. 4A is a balloon
300, is positioned through the opening 103 of each of the
renal arteries 102 and subsequently inflated. In other words,
and as shown in FIG. 4A, a distal portion of the balloon 300
is positioned and temporarily secured within the renal artery
102 while a proximal portion of the balloon 300 remains
within the aorta 101 itself. The balloon 300 therefore acts as
a physical extension of the renal arteries 102 into the aorta
101.
Referring now specifically to FIG. SA, after the balloons
300 are positioned and inflated, the graft 210 is advanced
along the length of the aorta 101, such that the balloons 300
engage the leading edge 232 of the flexible fabric 230 and
cause the flexible fabric 230 to deflect and form scallops 240
along the leading edge 232 of the flexible fabric 230 and
within the indentations 226 of the framework 220. Advantageously, since the balloons 300 are inflated so as to be
secured within the renal arteries 102, the scallops 240 are
aligned with each of the renal arteries 102. That is to say, the
system and method of the present invention are configured
such that the balloons 300, or other such deflection means,
align the indentations 226 of the framework 220 with the
renal arteries 102 so that the resulting scallops 240 are also
properly aligned with the renal arteries 102. In particular, as
the graft 210 is advanced along the length of the aorta 101
and the balloons 300 begin to deflect the flexible fabric 230,
the balloons 300 engage the indentations 226 of the underlying framework 220. As the balloons 300 slide down the
framework 220 and into the indentations 226, the balloons
300 cause the graft 210 to rotate so as to aligned the
indentation 226 with the balloon 300 extending from the
renal artery 102. As shown in FIG. SA, the resulting scallops
240 formed within the indentation 226 are therefore aligned
with the balloons 300 and no scallops are formed along the
portion of the leading edge 232 where the balloons 300 are
not present, as further discussed below.
As shown in FIGS. 4A and SA, in this exemplary implementation of the method of the present invention, the
balloons 300 are introduced by a distal approach, such that
the balloons 300 pass through the graft 210 itself before
being positioned through the openings 103 of the renal
arteries 102. Referring now specifically to FIGS. 4B and 5B,
in another exemplary implementation of the present invention, the balloons 300 are introduced by a proximal
approach. As shown in FIG. 5B, after the balloons 300 are
positioned and inflated, the graft 210 is still advanced along
the length of the aorta 101, such that the leading edge 232
of the flexible fabric 230 engages the balloons 300 forming
the scallops 240 within the indentations 226 of the framework 220 while leaving the remainder of the leading edge
232 straight in substantially the same manner as discussed
above with respect to FIGS. 4A and SA.
Regardless of the particular direction of approach, it is
contemplated that, rather than a balloon, the deflection
means can be a sheath or other similar device known in the
art which, after being introduced into the renal arteries 102,
is capable of deflecting the leading edge 232 of the flexible

fabric 230 when the graft 210 is advanced along the length
of the aorta 101. Likewise, a cutting balloon or other similar
device can be used to cut or tear the flexible fabric 230 in
addition to, or instead of deflecting the leading edge 232 of
the flexible fabric 230.
Referring once again to FIG. 3, in this exemplary implementation of the method of the present invention, the graft
210 is shown in a substantially deployed configuration
within the aorta 101 such that the flexible fabric 230 of the
graft 210 is adjacent to the inner wall of the aorta 101 with
the leading edge 232 of the flexible fabric 230 immediately
distal to the openings 103 of the renal arteries 102. Furthermore, in this exemplary implementation of the method of the
present invention, the graft 210 remains in the substantially
deployed configuration while the balloons 300 are positioned through the opening 103 of the renal arteries 102
(shown in FIGS. 4A and 4B) and while the graft 210 is
advanced along the length of the aorta 101 (shown in FIGS.
SA and 5B). In some other exemplary implementations,
however, a dual stage graft can be used, in which the graft
is first partially deployed within the aorta, allowing for
adjustments in the position of the graft. The graft is then
fully deployed at which point the graft is effectively connected to the aorta with a sufficient seal between the graft
and the inner wall of the aorta. For example, in some
particular embodiments, a dual stage graft is partially
deployed prior to positioning the balloons, or other similar
deflection means, within the openings of the renal arteries.
The dual stage graft is then fully deployed after the scallops
are formed along the leading edge of the endoluminal graft.
Of course, depending on the particular form of the graft
provided, other variations in the order of the steps of
positioning the graft, positioning the deflection means,
advancing the graft, forming the scallops, and deploying the
graft are also contemplated without departing from the spirit
and scope of the present invention.
Regardless of the particular implementation of the method
of forming the scallops of the present invention, and referring now specifically to FIG. 6, after the scallops 240 are
formed along the leading edge 232 of the graft 210, the
balloons 300 are deflated and removed from the openings
103 to the renal arteries 102. The graft 210 is now positioned
within the aorta 101 with a proximal seal made in the healthy
portion 104 of the aorta 101 proximal to the aneurysm 105.
Advantageously, in the exemplary system and method of the
present invention, it is only the portion (or portions) of the
leading edge 232 of graft 210 which is aligned with the
openings 103 to the renal arteries 102 (i.e., where the
balloons 300 were previously positioned) that is deflected to
create the scallops 240. The remaining portion of the leading
edge 232 is not deflected and extends above the openings
103 to the renal arteries 102. As such, even though the
aneurysm 105 shown in FIGS. 3-6 is relatively close to the
renal arteries 102, the area of the flexible fabric 230 in
contact with the healthy portion 104 of the aorta 101
provides a sufficient seal while still preserving blood flow to
the renal arteries 102.
In addition to the graft 210 described above, and referring
now to FIG. 7, in some exemplary embodiments of the
present invention, the system further includes stents 400
which are positioned adjacent to the scallop 240 of the graft
210 and extending through the opening 103 to the renal
artery 102. In particular, in some exemplary implementations of the method of the present invention, the stents 400
are positioned after the scallops 240 are formed and the
balloons 300 are deflated and removed from the openings
103. It is contemplated that the stents 400 help maintain the
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shape and alignment of the scallops 240, thus limiting the
possibility of a subsequent decrease in flow to the renal
arteries 102 caused, for example, by a shift in the position of
the graft 210 within the aorta 101. The stents 400 included
in the system of the present invention can be any one of a
number of stents known in the art.
Referring now to FIGS. 8-11, in another exemplary
embodiment of the system of the present invention, a
delivery catheter 1200 and endoluminal graft 1210 are
provided similar to the delivery catheter 200 and endoluminal graft 210 described above with respect to FIGS. 3-6,
except the delivery catheter 1200 shown in FIGS. 8-11
further includes a plurality of tethers 1250 that connect the
nosecone 1204 of the delivery catheter 1200 to the peaks
1224 of the metal framework 1220 of the graft 1210. With
respect to the graft 1210 in particular, similar to the graft 210
described above, the graft 1210 shown in FIGS. 8-11 comprises a framework 1220 of curvilinear elements and a
flexible fabric 1230 surrounding the framework 1220. The
uppermost curvilinear element of the framework 1220
includes a plurality of alternating peaks 1224 and indentations 1226 with a leading edge 1232 of the flexible fabric
1230 extending between the peaks 1224 substantially flat
across the indentations 1226 defined by the framework 1220
of the graft 1210.
The delivery catheter 1200 is also substantially the same
as the delivery catheter 200 described above with respect to
FIG. 3-6 and includes a nose cone 1204 which is advanced
along a guidewire 1202 and which precedes a guidewire
lumen 1206 that is disposed around the guidewire 1202, but,
as previously mentioned, the system shown in FIGS. 8-11
includes a plurality of tethers 1250 that connect the peaks
1224 of the metal framework 1220 of the graft 1210 to the
nosecone 1204 of the delivery catheter 1200. The tethers
1250 provide a connection between the delivery catheter
1200 and the leading edge 1232 of the graft 1210 which
facilitates the placement of the graft 1210 and formation of
the scallops 1240, as discussed below.
Referring now specifically to FIG. 8, the graft 1210 is
initially positioned within the aorta 101 in substantially the
same manner as described above with respect to FIG. 3
except that the tethers 1250 provide additional control in the
placement of the leading edge 1232 adjacent to the openings
103 of the renal arteries 102. Specifically, by advancing the
guidewire lumen 1206 along the guidewire 1202, the nose
cone 1204 is also advanced, which, in tum pulls the graft
1210 along the length of the aorta 101 by way of the tethers
1250. As such, the graft 1210 can advantageously be
advanced by a pulling mechanism in addition to a pushing
mechanism.
Referring now to FIG. 9, after positioning the graft 1210,
a balloon 1300, is positioned through the opening 103 of
each of the renal arteries 102 and subsequently inflated, in
substantially the same marmer as describe above with
respect to FIG. 4A. Of note, in the exemplary implementation shown in FIG. 9, the balloons 1300 are introduced with
a distal approach such that the balloons 1300 pass through
the graft 1210 itself before being passed between two of the
tethers 1250 and positioned through the openings 103 of the
renal arteries 102. In other implementations of the present
invention, however, the balloons 1300 are instead introduced by a proximal approach in substantially the same
manner as described above with respect to FIG. 4B.
Regardless, and referring now to FIG. 10, after the
balloons 1300 are positioned and inflated, the graft 1210 is
advanced along the length of the aorta 101, such that the
balloons 1300 engage the leading edge 1232 of the flexible

fabric 1230 and cause the flexible fabric 1230 to deflect and
form scallops 1240 along the leading edge 1232 and within
the indentation 1226 of the framework 1220 in substantially
the same manner as described above with respect to FIG.
SA. As mentioned above, the tethers 1250 provide additional
control when forming the scallops 1240 by allowing the
graft 1210 to be pulled upward by the plurality of tethers
1250, as opposed to simply being pushed upward. Except
where stated otherwise above, all other aspects of the system
and method of the present invention shown and described
above with respect to FIGS. 8-10 are substantially the same
as described above with respect to FIGS. 3-6.
Referring now to FIG. 11, as a further refinement of the
present invention, it is contemplated that, in some embodiments, the tethers 1250 are selectively connected to the
peaks 1224 of the framework 1220 of the graft 1210. As
such, the tethers 1250 can subsequently detach from the
graft 1210 for removal along with the delivery catheter 1200
after forming the scallops 1240.
Referring now to FIG. 12, in another exemplary embodiment of the present invention, an exemplary endoluminal
graft 2210 is provided similar to the exemplary endoluminal
graft 210 described above with respect to FIGS. 3-6, except
the graft 2210 shown in FIG. 12 further includes a plurality
oftransrenal fixation portions 2260 which are secured to the
healthy portion 104 of the aorta 101 distal of the graft 2210,
thus further assuring that the graft 2210 is effectively
secured to the healthy portion 104 of the aorta 101 and an
effective seal is formed proximal to the aneurysm 105. With
respect to the graft 2210 in particular, and similar to the
exemplary grafts 210, 1210 described above, the graft 2210
shown in FIG. 12 comprises a framework 2220 of curvilinear elements and a flexible fabric 2230 surrounding the
framework 2220. The uppermost curvilinear element of the
framework 2220 includes a plurality of alternating peaks
2224 and indentations 2226 with a leading edge 2232 of the
flexible fabric 2230 that initially extends between the peaks
2224 substantially flat across the indentations 2226 defined
by the framework 2220 of the graft 2210 and which ultimately forms the scallops 2240 in the indentations 2226
shown in FIG. 12. The delivery catheter 2200 shown in FIG.
12 is also substantially the same as the delivery catheter 200
described above with respect to FIGS. 3-6 and includes a
nose cone 2204 which is advanced along a guidewire 2202
and which precedes a guidewire lumen 2206 that is disposed
around the guidewire 2202. In the embodiment shown in
FIG. 12, each of the transrenal fixation portions 2260 are
connected to two adjacent peaks 2224 of the framework
2220 of the graft 2210 and extend away from the leading
edge 2232, terminating at a hook 2264 configured to engage
the interior wall of the healthy portion 140 of the aorta 101
when deployed.
Referring still to FIG. 12, with the inclusion of the
transrenal fixation portions 2260, each of the balloons 2300
must pass through one of the transrenal fixation portions
2260 and above the leading edge 2232 of the flexible fabric
2230 when being positioned through the openings 103 of
each of the renal arteries 102. In at least some embodiments,
the flexible fabric 2230 of the graft 2210 is radiographically
"invisible" making it difficult to determine the exact position
of the leading edge 2232 of the flexible fabric 2230 and,
therefore, the position of the balloons 2300 in relation to the
leading edge 2232 of the flexible fabric 2230. As such, in
this exemplary embodiment shown in FIG. 12, a plurality of
radiographic markers 2262 are positioned at the intersection
of the transrenal fixation portions 2260 and the peaks 2224
of the metal framework 2220. The radiographic markers
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2262 allow an operate to visually monitor the position of the
markers 2262, and thus the leading edge 2232 of the flexible
fabric 2230, in relation to the balloons 2300 and/or renal
arteries 102 to ensure that the balloons 2300 extend between
one of the transrenal fixation portions 2260 and the leading
edge 2232 of the flexible fabric 2230. As shown in FIG. 12,
when the scallops 2240 are formed, the balloons 2300 are
substantially below the line of markers 2262 and therefore,
an operator can ensure that the scallops 2240 are appropriately formed within the indentations 2226 of the metal
framework 2220 of the graft 2210. Except where stated
otherwise above, all other aspects of the system and method
of the present invention shown and described above with
respect to FIG. 12 are substantially the same as the system
and method described above with respect to FIGS. 3-6.
Referring now to FIG. 13, in another exemplary system of
the present invention, an endoluminal graft 3210 is provided
which includes additional features which assist in securing
the graft 3210 to the healthy portion 104 of the aorta 101 and
a forming an effective seal proximal to the aneurysm 105.
Similar to the exemplary endoluminal grafts 210, 1210,
2210 described above, the endoluminal graft 3210 shown in
FIG. 13 comprises a framework 3220 of curvilinear elements and a flexible fabric 3230 surrounding the framework
3220. The uppermost curvilinear element of the framework
3220 includes a plurality of alternating peaks 3224 and
indentations 3226 with a leading edge 3232 of the flexible
fabric 3230 initially extending between the peaks 3224
substantially flat across the indentations 3226 defined by the
framework 3220 of the graft 3210. Furthermore, and similar
to the exemplary graft 2210 shown in FIG. 12, the graft 3210
shown in FIG. 13, further includes transrenal fixation portions 3260, 3266 as well as a plurality of radiographic
markers 3262. The radiographic markers 3262 shown in
FIG. 13 are substantially similar to the radiographic markers
2262 described above with respect to FIG. 12, but the
transrenal fixation portions 3260, 3266 comprise both a
mid-crown of fixation portions 3260 and a top-crown of
fixation portions 3266. Furthermore, unlike any of the
previously describe grafts, the graft 3210 shown in FIG. 13
also includes two sealing rings 3268 which are injectable
with a polymer. One such exemplary graft 3210 is the
OVATION® graft which is produced by TriVascular, Inc. of
Santa Rosa, Calif. (OVATION® is a registered trademark of
TriVascular, Inc. of Santa Rosa, Calif.).
In an exemplary implementation of the method of the
present invention which uses a graft 3210 having both a
mid-crown 3260 and a top-crown 3266 of fixation portions,
the first step of deploying the graft 3210 is to release the
mid-crown of fixation portions 3260. A balloon (not shown)
is passed through one of the fixation portions 3260 of the
mid-crown and above the leading edge 3232 of the flexible
fabric 3230 when being positioned through the opening 103
of the renal artery 102. The balloon is then inflated and the
scallop (not visible) is formed substantially as described
above. The top-crown of fixation portions 3266 is then
released, securing the graft 3210 in place in the aorta 101.
Finally, polymer is injected into the sealing rings 3268 as
well as other channels built into the graft 3210 forming a
seal with the healthy portion 104 of the aorta 101. Except
where stated otherwise above, all other aspects of the system
and method of the present invention shown and described
above with respect to FIG. 13 are substantially the same as
the system and method described above with respect to
FIGS. 3-6.
Referring now to FIG. 14, in another exemplary implementation of the method of the present invention, a scallop

4242 is formed at the distal seal zone of another exemplary
endoluminal graft 4210. The endoluminal graft 4210 is
substantially the same as the endoluminal graft 210
described above with respect to FIGS. 3-6 except that the
scallop 4242 is formed at a distal edge 4234 of the graft
4210. With respect to the graft 4210 in particular, similar to
the graft 210 described above, the graft 4210 shown in FIG.
14 comprises a framework 4220 of curvilinear elements and
a flexible fabric 4230 surrounding the framework 4220. The
lowermost curvilinear element of the framework 4220
includes a plurality of alternating peaks 4224 and indentations 4226 with a distal edge 4234 of the flexible fabric 4230
initially extending between the peaks 4224 substantially flat
across the indentations 4226 defined by the framework 4220
of the graft 4210. In an exemplary implementation of the
method of the present invention, the graft 4210 is first
positioned within the aorta 101 and extending through the
aneurysm 105 and into a healthy portion 107 of the aorta 101
distal to the aneurysm 105 with the distal edge 4234 of the
flexible fabric 4230 positioned adjacent to an opening to a
branching artery 108. Next, a balloon 4300 is positioned
through the opening to the branching artery 108 and subsequently inflated and the graft 4210 is advanced along the
length of the aorta 101, such that the balloon 4300 engages
the distal edge 4234 of the flexible fabric 4230 causing the
flexible fabric 4230 to deflect and form a scallop 4242 in
substantially the same manner previously discussed. After
securing the graft 4210 in place, the balloon 4300 is then
deflated and removed.
Although the above implementations of the exemplary
method of the present invention are described with respect
to implanting the endoluminal graft within the aorta of a
patient, it is of course, understood that similar methods are
applicable to other blood vessels of the patient where an
aneurism, or other similarly diseased portion of the blood
vessel, is positioned near one or more branching arteries.
One of ordinary skill in the art will recognize that additional embodiments are possible without departing from the
teachings of the present invention. This detailed description,
and particularly the specific details of the exemplary
embodiments disclosed therein, is given primarily for clarity
of understanding, and no unnecessary limitations are to be
understood therefrom, for modifications will become obvious to those skilled in the art upon reading this disclosure
and may be made without departing from the spirit or scope
of the present invention.
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What is claimed is:
1. A method of implanting an endoluminal graft, comprising:
positioning an endoluminal graft within a primary vessel
with a leading edge of the endoluminal graft adjacent to
an opening to a branching vessel;
positioning a deflection means through the opening to the
branching vessel adjacent to the leading edge of the
endoluminal graft;
advancing the endoluminal graft along the length of the
primary vessel such that the deflection means engages
the leading edge of the endoluminal graft and forms a
scallop in-situ along the leading edge of the endoluminal graft.
2. The method of claim 1, wherein the endoluminal graft
includes a framework defining a plurality of indentations
adjacent to the leading edge of the endoluminal graft and a
flexible fabric surrounding the framework and forming the
leading edge of the endoluminal graft, and wherein the
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method further comprises a step of aligning one of the
10. The method of claim 1, and further comprising a step
plurality of indentations with the opening to the branching
of positioning a stent adjacent to the scallop so as to extend
vessel.
through the opening to the branching vessel.
3. The method of claim 2, wherein the scallop is formed
11. The method of claim 9, and further comprising a step
within one of the plurality of indentations.
5 of positioning a stent adjacent to the scallop such that the
4. The method of claim 2, wherein, upon advancing the
stent extends through the opening to the branching vessel.
endoluminal graft along the length of the primary vessel, the
12. A method of implanting an endoluminal graft, comdeflection means aligns the one of the plurality of indentaprising:
tions with the opening to the branching vessel.
providing an endoluminal graft having a leading edge, the
5. The method of claim 1, wherein the endoluminal graft
10
endoluminal graft including a framework defining a
includes a framework defining a plurality of indentations
adjacent to the leading edge of the endoluminal graft, a
plurality of indentations adjacent to the leading edge of
flexible fabric surrounding the framework and forming the
the endoluminal graft, a flexible fabric surrounding the
leading edge of the endoluminal graft, and one or more
framework and forming the leading edge of the endolutransrenal fixation portions connected to the framework and
minal graft, and one or more transrenal fixation por15
extending away from the leading edge of the endoluminal
tions which are each connected to the framework and
graft, and wherein the method further includes passing the
extend away from the leading edge of the endoluminal
deflection means through one of the transrenal fixation
graft;
portions and above the leading edge of the endoluminal
positioning
the endoluminal graft within a primary vessel
graft.
with the leading edge of the endoluminal graft adjacent
6. The method of claim 1, wherein the deflection means 20
to an opening to a branching vessel;
is a balloon, and wherein the method further comprises
passing a deflection means through one of the transrenal
inflating the balloon within the branching vessel.
fixation portions and above the leading edge of the
7. The method of claim 1, wherein the step of positioning
endoluminal graft;
the endoluminal graft comprises:
positioning the deflection means through the opening to
inserting the endoluminal graft within the primary vessel 25
the branching vessel;
when the endoluminal graft is in an undeployed conadvancing
the endoluminal graft along the length of the
figuration; and
primary vessel such that the deflection means engages
deploying the endoluminal graft such that the leading
the leading edge of the endoluminal graft and forms a
edge of the endoluminal graft is adjacent to an inner
scallop in-situ along the leading edge of the endolumi30
wall of the primary vessel.
nal graft and within one of the plurality of indentations.
8. The method of claim 1, and further comprising:
13. The method of claim 12, wherein, upon advancing the
partially deploying the endoluminal graft prior to posiendoluminal
graft along the length of the primary vessel, the
tioning the deflection means through the opening to the
deflection means aligns the one of the plurality of indentabranching vessel; and
fully deploying the endoluminal graft after forming the 35 tions with the opening to the branching vessel.
14. The method of claim 13, wherein the deflection means
scallop along the leading edge of the endoluminal graft.
is a balloon, and wherein the method further comprises
9. The method of claim 1, and further comprising a step
inflating the balloon within the branching vessel.
of removing the deflection means from the opening to the
branching vessel.
* * * * *

